Nature Medicine, Published online: 10 June 2025; doi:10.1038/s41591-025-03703-w
Estimates of chikungunya virus prevalence across 180 countries and territories show that Southeast Asia, Africa and the Americas carry the most substantiative burden, which would require reactive vaccine campaigns against new outbreaks and routine immunization in heavily endemic areas to reduce transmission.
Comments
No Trackbacks.